𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis of bridged catechol—homocysteine derivatives as potential inhibitors of catechol O-methyltransferase

✍ Scribed by O. William Lever Jr.; Clifton Hyman; Helen L. White

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
487 KB
Volume
73
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis

Applications of Nuclear Magnetic

Resonance Spcctroscopy in Organic Chemistry." 2nd cd., Pergamon. Oxford. 1969. p. 204. and references therein.

(

I ) I.. Jung and P. Cordicr. Hull. Soc. Phartn. Srrushourg. 8. 89 (1965); through Chrw7. Ahstr.. 66, 31992 (1967). (22) K . Pawclc/yk. K. Adamski, and E. Stcpien, Farm. Pol.. 28, 285 (1972); through C'hetif. Absrr.. 77. 39352 (1972). (23) A. Albert and E. P. Serjeanl. "The Determination of Ionization Constants," 2nd cd.. Chapman and Ilall. London, 1971. p. 87.

A C K N O W LEIKMENTS

The authors thank William M. Ment and Sharon R . Reed of the Baltimore District I.aboratory. U S . Food and Drug Administration, for calling attention to the possibility of the problem addrcsscd i n this study.

📜 SIMILAR VOLUMES

Synthesis of two 14C-labelled catechol-O
Synthesis of two 14C-labelled catechol-O-methyltransferase inhibitors
✍ Carita Karlsson; Erkki Honkanen 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 162 KB

14C-labelled 3-(3,4dihydroxy-5-nitrophenylmethylidene)-2,4-pentanedione (4 and 14C-labelled E-N,NdiethyI-Zcyano-3-(3,4-dih droxy 5-nitropheny1)acryl-Key words: carbon-14 labelling, synthesis, COMT-inhibitor. amide (5) have been synthesized from (carbonyl-A Clvanillin.

Catechol-O-methyltransferase inhibitors:
Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease
✍ Jasper Dingemanse 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

Substitution therapy with levodopa and a peripheral inhibitor of aromatic L-amino acid decarboxylase (AADC) is the cornerstone in the treatment of Parkinson's disease. Chronic therapy with levodopa, however, is associated with the occurrence of motor complications that are partially related to the p

Activation of catechol-O-methyltransfera
Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons
✍ Guowei Huang; Magdalena Dragan; David Freeman; John X. Wilson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

## Abstract Elevation of the total homocysteine (tHcy) concentration in plasma has been implicated in neurodegeneration in patients with stroke, dementia, Alzheimer disease, and Parkinson disease. Because the mechanisms controlling brain tHcy are unknown, the present study investigated its synthesi

Association of catechol-O-methyltransfer
Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials
✍ Georg Juckel; Wolfram Kawohl; Ina Giegling; Paraskevi Mavrogiorgou; Christine Wi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

## Abstract ## Objective The loudness dependence of auditory evoked potentials (LDAEP) provides a measure of the central serotonergic activity. As dopamine transporter availabilities also correlate with LDAEP, a dopaminergic influence is probable. The enzyme catechol‐O‐methyltransferase (COMT) is

The Lipophilicity Behavior of Three Cate
The Lipophilicity Behavior of Three Catechol-O-methyltransferase (COMT) Inhibitors and Simple Analogues
✍ Laura Novaroli; Geraldine Bouchard Doulakas; Marianne Reist; Barbara Rolando; Ro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 German ⚖ 141 KB

The ionization and lipophilicity properties of the second-generation catechol-O-methyltransferase (COMT) inhibitors entacapone (1), nitecapone (2), and tolcapone (3) which share the same nitrocatechol structure but have remarkably different pharmacokinetic profiles are investigated to identify relat